NCT04657965View on ClinicalTrials.gov

LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

January 15, 2024

Study Completion Date

January 15, 2027

Conditions
Infectious DiseasesHematological Malignancies
Interventions
DRUG

LMP1 CAR T-cells

Each subject receive LMP1 CAR T-cells by intravenous infusion

Trial Locations (1)

310003

The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER